Filter
1937
Filtered Results: 1937
Text search:
Ministry
of
Health,
Kenya
Featured
Recommendations
140
New Publications
468
Language
Document type
No document type
1080
Studies & Reports
390
Guidelines
180
Manuals
103
Strategic & Response Plan
79
Training Material
47
Fact sheets
24
Situation Updates
21
Infographics
6
Resource Platforms
4
Brochures
1
App
1
Online Courses
1
Countries / Regions
Kenya
354
Uganda
83
Global
74
Africa
60
Ethiopia
57
Nigeria
48
Rwanda
39
Tanzania
37
Malawi
36
Congo, Democratic Republic of
33
Zambia
32
South Sudan
29
Sierra Leone
21
East and Southern Africa
21
Liberia
20
Zimbabwe
20
Senegal
19
Ghana
19
India
18
South Africa
18
Lesotho
17
Guinea
14
Nepal
14
Mozambique
13
West and Central Africa
13
Somalia
11
Namibia
11
Cameroon
10
Botswana
10
Bangladesh
9
Benin
9
Central African Republic
9
Madagascar
9
Burkina Faso
8
Myanmar / Burma
8
Pakistan
7
Eswatini/ Swaziland
7
Ukraine
7
Middle East and North Africa
7
Cambodia
6
Indonesia
6
South–East Asia Region
6
Western and Central Europe
6
Afghanistan
5
Sudan
5
Asia
5
Côte d’Ivoire / Ivory Coast
4
Togo
4
Syria
4
Angola
4
Yemen
4
Latin America and the Carribbean
4
Russia
4
Mali
3
Philippines
3
Iraq
3
Jordan
3
Chad
3
Thailand
3
Colombia
3
Sri Lanka
3
Eastern Europe
3
Iran
3
Niger
2
Haiti
2
Lebanon
2
Gambia
2
China
2
Brazil
2
Burundi
2
Mexico
2
Eastern Europe and Central Asia
2
Southern Africa
2
Laos
2
Guinea-Bissau
1
Morocco
1
Saudi Arabia
1
Germany
1
Papua New Guinea
1
Vanuatu
1
Argentina
1
Peru
1
North Macedonia
1
Ecuador
1
Greece
1
Western Pacific Region
1
Solomon Islands
1
Palestine
1
North Korea
1
Albania
1
Djibouti
1
Canada
1
Tajikistan
1
Estonia
1
Georgia
1
Vietnam
1
Gabon
1
Japan
1
Mauritius
1
Tunisia
1
Morocco
1
Authors & Publishers
Publication Years
Category
Countries
789
Clinical Guidelines
130
Women & Child Health
121
Public Health
114
Key Resources
83
Capacity Building
44
Pharmacy & Technologies
13
Annual Report MEDBOX
1
Toolboxes
HIV
218
Mental Health
122
COVID-19
120
Disability
117
TB
100
AMR
73
Planetary Health
73
Caregiver
62
Rapid Response
53
NTDs
46
Ebola
42
Conflict
35
Global Health Education
31
Refugee
27
Pharmacy
26
Health Financing Toolbox
21
Natural Hazards
18
NCDs
15
Cholera
13
Polio
8
Social Ethics
7
Zika
2
Specific Hazards
2
South Sudan
1
Health Financing
1
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neuro...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health<...
The objectives of the meeting were:
1. To update the current status of the disease transmission, country capacities and plans for tackling the disease.
2. To understand the epidemiology includin...
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.
Since the last situation report on the multi-country outbreak of cholera was published on 1 June 2023 (covering data reported until 15 of May), no new country reported a cholera outbreak. In total, ...
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to h... facilities or a qualified health care provider and do not receive the necessary care in a timely fashion. Without rapid detection of danger signs and access to effective treatment, including pre-referral treatment that can be administered in the community level, many of these children with severe malaria die.
In situations where there is no immediate access to a health care facility, WHO recommends the administration of a standard dose of an effective antimalarial medicine as pre-referral treatment before referral to a facility at which complete treatment can be administered.
Rectal artesunate is the WHO-recommended pre-referral intervention in situations where artesunate injection are not feasible for children under the age of 6 years with suspected severe malaria. The intervention reduces the risk of death or permanent disability by up to 50% provided the child is referred to a health facility at which complete treatment can be administered.
This field guide is aimed at supporting the effective deployment of RAS as pre-referral treatment of suspected severe malaria in line with the WHO malaria guidelines.
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner drug ...
Pneumonia and diarrhoea account for 23% of under-five mortality and were responsible for an estimated 1.17 million deaths in children under five globally. Furthermore, pneumonia and diarrhoea were responsible for 18% ... mortality in children 5–9 years of age, resulting in an estimated 86 000 preventable deaths globally in 2021. Existing World Health Organization (WHO) guidance on the clinical management of pneumonia and diarrhoea has mainly focused on children less than 5 years of age.
The report summarizes the estimates of the burden of disease attributable to unsafe drinking water, sanitation, and hygiene for the year 2019 for four hea... outcomes - diarrhoea, acute respiratory infections, soil-transmitted helminthiases, and undernutrition - which are included in the reporting of the Sustainable Development Goal indicator 3.9.2. The report includes estimates at global, regional and country level for 183 WHO Member States.
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations...
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms ... TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, especially when further testing of sputum smear-negative specimens is necessary.
Information note.
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and hepati...
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and hepati...
The Strategic plan aims to ensure alignment of preparedness and readiness actions in the nine countries focusing on eight technical areas: strengthening multisectoral coordination; surveillance for early detection; laboratory diagnostic capacity; po...
The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing ... initiation of antiretroviral therapy (ART) for all people living with HIV.
WHO recommends that a package of screening, prophylaxis, rapid ART initiation and intensified adherence interventions be offered to everyone living with HIV presenting with advanced disease.
WHO strongly recommends that rapid ART initiation should be offered to people living with HIV following confirmed diagnosis and clinical assessment. Rapid initiation of ART is defined as within seven days of HIV diagnosis. WHO further strongly recommends ART initiation on the same day as HIV diagnosis based on the person’s willingness and readiness to start ART immediately, unless there are clinical reasons to delay treatment.
WHO recommends that a package of screening, prophylaxis, rapid ART initiation and intensified adherence interventions be offered to everyone living with HIV presenting with advanced disease.
WHO strongly recommends that rapid ART initiation should be offered to people living with HIV following confirmed diagnosis and clinical assessment. Rapid initiation of ART is defined as within seven days of HIV diagnosis. WHO further strongly recommends ART initiation on the same day as HIV diagnosis based on the person’s willingness and readiness to start ART immediately, unless there are clinical reasons to delay treatment.
The WHO Guidelines on risk reduction of cognitive decline and dementia provide evidence-based recommendations on lifestyle behaviours and interventions to delay or prevent cognitive decline and dementia. These WHO Guidelines are an important tool fo...
Journal of Infection and Public Health 12 (2019) 213–223
Recommendations for a public health approach
HIV/AIDS Programme
